Print

Merrimack Pharmaceuticals Inc. Reports Second Quarter 2012 Financial Results  
8/10/2012 9:28:36 AM

CAMBRIDGE, Mass., Aug. 10, 2012 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK), a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer, today announced its second quarter 2012 financial results.
//-->